3 unknown, 1 completed. 4 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Unknown 3, Completed 1 |
| Phase 1 | 1 | Completed 1 |
Follow Shen Lin: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-HER2 Therapy in Patients of HER2 Positive Metastatic Carcinoma of Digestive System chemotherapy in combination with trastuzumab for arm1, chemotherapy in combination with trastuzumab for arm2, chemotherapy in combination with trastuzumab for arm3 - Targeted Therapy, HER2 | Phase 2 | Unknown | Shen Lin | 100 | 2017-07-01 | 2019-07-19 |
| Sequential Paclitaxel Plus Cisplatin Chemotherapy and Radiotherapy as 1st Line Treatment for Esophageal Squamous Cell Cancer Sequential chemotherapy (paclitaxel 175mg/m2 d1; cisplatin 37.5mg/m2 d1,d2) and radiotherapy - Esophageal Squamous Cell Cancer | Phase 2 | Unknown | Shen Lin | 70 | 2013-12-01 | 2013-12-19 |
| Sequential Paclitaxel Chemotherapy and Radiotherapy as 1st Line Treatment for Elderly Esophageal Squamous Cell Cancer Sequential chemotherapy （paclitaxel 80mg/m2 d1,d8) and radiotherapy - Esophageal Squamous Cell Cancer, Elderly Patients | Phase 2 | Unknown | Shen Lin | 50 | 2013-12-01 | 2013-12-19 |
| Feasibility Study of SOL (S-1,Oral Leucovorin,and Oxaliplatin) for Colorectal Cancer in China S-1, leucovorin, oxaliplatin - Colorectal Cancer | Phase 1 / Phase 2 | Completed | Shen Lin | 20 | 2009-09-01 | 2015-05-19 |
Esophageal Squamous Cell Carcinoma (3) · Colorectal Neoplasms (2) · Biliary Tract Neoplasms (1)
Radiotherapy (2) · 26S proteasome non-ATPase regulatory subunit 13 (1) · Cisplatin (1) · Drug Therapy (1) · JPT1 protein, human (1) · Leucovorin (1) · Long-Term Synaptic Depression (1) · Oxaliplatin (1) · Paclitaxel (1) · S 1 (combination) (1) · Trastuzumab (1)
China (4)
Lin Shen, MD (2) · Lin Shen, Master (1)